Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

10BagR

Rank: Treasurer [?]

Points: 670 [?]

Votes: 20 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

in response to

Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

Nextblockbuster

posted on Jan 18, 2022 08:33AM

NBB

I doubt Eversana can announce anything until this news release was first made public. But I assume they will be a fast follower now.

Then, again I've assumed a lot in the past and you all know what that means...

Anyway, may all of our candles in the window be the tallest ever made and burn the brightest!